Get the Full Story, Without the Noise.
Published loading...Updated

FDA approves first cervical cancer screening device that can be used at home, company says

  • The FDA approved Teal Health's Teal Wand on May 9, 2025, as the first cervical cancer screening kit for at-home sample collection in the U.S.
  • This approval responded to low screening rates, as only one in four women receive regular cervical cancer tests despite CDC guidelines.
  • Teal Wand uses a swab inserted into the vagina to collect samples detecting HPV, the virus causing over 99% of cervical cancers, which are mostly sexually transmitted infections.
  • The company, based in San Francisco, will first market the prescription-required kit in California starting next month while working with insurers like Aetna to expand access.
  • This device may increase screening convenience and coverage, addressing inadequate screening linked to most cervical cancer cases and potentially improving early detection and treatment.
Insights by Ground AI
Does this summary seem wrong?
Podcasts & Opinions

226 Articles

All
Left
26
Center
93
Right
24
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 65% of the sources are Center
65% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

King5 News broke the news in Seattle, United States on Friday, May 9, 2025.
Sources are mostly out of (0)